Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Efficacy and Safety of Scheduled Versus As-Needed Firsekibart Administration for the Prevention of Gout Recurrence: A Multicenter, Open-Label, Randomized Controlled TrialGout FlaresNot yet recruitingNot applicable2026-06-01NCT07616531

1 results · Page 1 of 1

Swipe the table sideways for more columns.

11 results · Page 1 of 1